Susquehanna International Group’s Galectin Therapeutics Inc. - Warrants GALTW Stock Holding History

Susquehanna International Group’s Portfolio GALTW Stock Details GALTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-15,450	Closed	-$2K	–	10650
2016 Q3	$2K	Buy	+15,450	New	+$5.44K	﹤0.01%	8321

Other funds holding GALTW

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Susquehanna International Group's GALTW Position: Q4 2016 in Review

Susquehanna International Group sold out of Galectin Therapeutics Inc. - Warrants (GALTW) in Q4 2016, closing a stake of 15,450 shares — an estimated $2K sold.

Susquehanna International Group first reported a position in GALTW in Q3 2016 and held it in 1 quarter. The position peaked at $2K in Q3 2016. 4 funds tracked by Wall St. Rank hold GALTW as of Q4 2016.

Susquehanna International Group reported no remaining Galectin Therapeutics Inc. - Warrants position as of Q4 2016 after selling out during the quarter.
Susquehanna International Group sold 15,450 Galectin Therapeutics Inc. - Warrants shares in Q4 2016, an estimated $2K.
Susquehanna International Group first reported a position in Galectin Therapeutics Inc. - Warrants in Q3 2016 and held it in 1 quarter.
Susquehanna International Group's Galectin Therapeutics Inc. - Warrants position peaked at $2K in Q3 2016.
4 funds tracked by Wall St. Rank held Galectin Therapeutics Inc. - Warrants as of Q4 2016.

Based on Susquehanna International Group's 13F filing for Q4 2016, filed 14 Feb 2017.